195 related articles for article (PubMed ID: 30981768)
1. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
Gong F; Dong D; Zhang T; Xu W
Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FENDRR attenuates adriamycin resistance via suppressing MDR1 expression through sponging HuR and miR-184 in chronic myelogenous leukaemia cells.
Zhang F; Ni H; Li X; Liu H; Xi T; Zheng L
FEBS Lett; 2019 Aug; 593(15):1993-2007. PubMed ID: 31180580
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
Zhang G; Wang Q; Zhang X; Ding Z; Liu R
Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA
Zhao X; Wu J; Li Y; Ye F; Wang C
Bioengineered; 2021 Dec; 12(1):8698-8708. PubMed ID: 34697986
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
Wang R; Dong HX; Zeng J; Pan J; Jin XY
J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
[TBL] [Abstract][Full Text] [Related]
7. NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1.
Jiang P; Chen A; Wu X; Zhou M; Ul Haq I; Mariyam Z; Feng Q
J Cell Physiol; 2018 Jun; 233(6):4852-4863. PubMed ID: 29152741
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2.
Wang X; Yu X; Wei W; Liu Y
Environ Toxicol; 2020 Sep; 35(9):998-1006. PubMed ID: 32401390
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.
Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
[TBL] [Abstract][Full Text] [Related]
10. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.
Song H; Xu Y; Shi L; Xu T; Fan R; Cao M; Xu W; Song J
Biomed Pharmacother; 2018 Dec; 108():338-346. PubMed ID: 30227327
[TBL] [Abstract][Full Text] [Related]
11. HuR facilitates cancer stemness of lung cancer cells via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axis.
Zhang Y; Yang L; Ling C; Heng W
Biotechnol Lett; 2018 Apr; 40(4):623-631. PubMed ID: 29344850
[TBL] [Abstract][Full Text] [Related]
12. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
Su L; Han D; Wu J; Huo X
Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
[TBL] [Abstract][Full Text] [Related]
13. The miRNA-149-5p/MyD88 axis is responsible for ursolic acid-mediated attenuation of the stemness and chemoresistance of non-small cell lung cancer cells.
Chen Q; Luo J; Wu C; Lu H; Cai S; Bao C; Liu D; Kong J
Environ Toxicol; 2020 May; 35(5):561-569. PubMed ID: 31855318
[TBL] [Abstract][Full Text] [Related]
14. RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a.
Zhang L; Chen Y; Li C; Liu J; Ren H; Li L; Zheng X; Wang H; Han Z
Biomed Pharmacother; 2019 Jun; 114():108772. PubMed ID: 30909144
[TBL] [Abstract][Full Text] [Related]
15. Multiple Copies in T-Cell Malignancy 1 (MCT-1) Promotes the Stemness of Non-Small Cell Lung Cancer Cells via Activating Interleukin-6 (IL-6) Signaling through Suppressing MiR-34a Expression.
Li Y; Wang B; Gui S; Ji J
Med Sci Monit; 2019 Dec; 25():10198-10204. PubMed ID: 31891569
[TBL] [Abstract][Full Text] [Related]
16. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of lncRNAs in 3'-untranslated regions: CR933609 acts as a decoy to protect the INO80D gene.
Chang CC; Liu TY; Lee YT; Chen YC; Yeh KT; Lee CC; Chen YL; Lin PC; Chang YS; Chan WL; Liu TC; Chang JG
Int J Oncol; 2018 Jul; 53(1):417-433. PubMed ID: 29750421
[TBL] [Abstract][Full Text] [Related]
18. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137/PXN axis in non-small cell lung cancer.
Jiang H; Zhang H; Hu X; Li W
Int J Biol Macromol; 2018 May; 111():623-631. PubMed ID: 29337100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
